Smart Electronic Eyedrop Bottle for Unobtrusive Monitoring of Glaucoma Medication Adherence

Smart Electronic Eyedrop Bottle for Unobtrusive Monitoring of Glaucoma Medication Adherence

Glaucoma, the leading cause of irreversible blindness, affects >70 million people worldwide. Lowering intraocular pressure via topical administration of eye drops is the most common first-line therapy for glaucoma. This treatment paradigm has notoriously high non-adherence rates: ranging from 30%...

Full description

Bibliographic Details
Main Authors: Marcelo Aguilar-Rivera, Dieanira T. Erudaitius, Vincent M. Wu, Justin C. Tantiongloc, Dae Y. Kang, Todd P. Coleman, Sally L. Baxter, Robert N. Weinreb
Format: Article
Language:English
Published: MDPI AG 2020-04-01
Series:Sensors
Subjects:
Glaucoma
adherence
monitoring
sensors
alerts
clinical decision support
Online Access:https://www.mdpi.com/1424-8220/20/9/2570

Internet

https://www.mdpi.com/1424-8220/20/9/2570

Similar Items